Paras Healthcare Limited (parashlth) Q2 FY27: Revenue Up 23% Yoy to Rs. 511 Cr

Paras Healthcare Limited (PARASHLTH) announced its first unaudited consolidated financial results for the quarter and six months period ended September 30, 2026, since listing on the stock exchanges on October 28, 2026. The company reported robust revenue growth of 23% year-on-year to Rs. 511 crore in Q2 FY27.

Key Financial Highlights

The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) surged 43% year-on-year to Rs. 126.6 crore. The profit after tax (PAT) increased 3.3 times year-on-year to Rs. 40.4 crore.

Hospital Expansion and Performance

New hospitals at Srinagar and Kanpur more than doubled revenue in Q2 year-on-year to Rs. 84.4 crore, with an EBITDA margin of 18.7%. The half-year revenue stood at Rs. 981.2 crore, up 25.1% year-on-year, and the half-year PAT was Rs. 90.0 crore, 7.9 times higher than the previous year.

Future Outlook

Dr. Dharminder Kumar Nagar, Managing Director, Paras Healthcare Limited, highlighted the company’s commitment to deepening specialty programs, investing in advanced clinical technology, and expanding its presence in underserved markets of North India. The company plans to continue its growth trajectory with new hospital openings in Gurugram and Ludhiana by 2028.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Paras Healthcare Limited

Paras Healthcare Limited. Here’s a quick read on where the business and the stock stand today.

Symbol PARASHLTH not found in TradeAlone database.